Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript
Akoya Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.27.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,579,756 | $7,709,209 | 0.04% | |
2. | Parkman Healthcare Partners Greg Martinez | 674,787 | $3,292,961 | +29% | 0.46% |
3. | Millennium Management Israel Englander | 157,368 | $767,956 | -72% | 0% |
4. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 155,800 | $760,304 | +21% | 0% |
5. | Osterweis Capital Management John Osterweis | 126,131 | $615,519 | 0.03% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$4.60 | 7,000 | Officer | 20,000 | 2023-09-07 | Filing | |
$4.60 | 13,000 | Officer | 13,000 | 2023-09-07 | Filing | |
$5.00 | 20,000 | Officer | 20,000 | 2023-06-12 | Filing | |
$5.00 | 20,000 | Director | 20,000 | 2023-06-12 | Filing | |
$5.00 | 20,000 | Director | 28,500 | 2023-06-12 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$4.97 | 7,500 | Officer, Director | 231,868 | 2024-03-20 | Filing | |
$4.94 | 7,500 | Officer, Director | 231,868 | 2024-03-13 | Filing | |
$4.94 | 7,500 | Officer, Director | 224,368 | 2024-03-13 | Filing | |
$4.48 | 7,500 | Officer, Director | 152,563 | 2023-12-19 | Filing | |
$4.25 | 7,500 | Officer, Director | 152,563 | 2023-12-12 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 4,697,785 | $22,925,191 | 20.08% | |
2. | 1,408,157 | $6,871,807 | 0% | |
3. | 1,372,232 | $6,696,492 | 0% | |
4. | 620,433 | $3,027,712 | 0.19% | |
5. | 515,317 | $2,514,747 | 0.06% |